A.O. Cardarelli

Naples 80131

0 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia (AML), Renal Cell Carcinoma (RCC), Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed